Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Exploring the promise of DUBs: Mission teams up with Pfizer

Pfizer Ventures has expanded its relationship with DUB-focused Mission Therapeutics by leading a $15m funding round. The pharma giant’s core company has also signed a scientific partnership to validate promising DUB drug targets. What potential do DUBs have in treating disease?

Close
Close
Close

Go Top